Progyny (NASDAQ:PGNY): An Affordable Growth Play With Double-Digit Earnings Expansion
Barclays Downgrades Progyny to Equal-Weight, Raises Price Target to $34
Progyny (PGNY): Strong Growth with Technical Setup Quality
BTIG Maintains Buy on Progyny, Raises Price Target to $40
Progyny, Inc. Announces Details for Its Second Quarter 2026 Results Report
Canaccord Genuity Maintains Buy on Progyny, Raises Price Target to $36
Progyny COO Cummings Sells 3,437 Shares for $109,000 -- Here's What That Means for Investors
Progyny (PGNY) Stock May Be 50% Undervalued On Fresh Analyst Upgrades
Does Rising Analyst Optimism On June Trends Reframe Progyny’s (PGNY) Employer-Demand Story?
Progyny, Inc. (PGNY) Hit a 52 Week High, Can the Run Continue?
Progyny (PGNY) Stock Is Up, What You Need To Know
Keybanc Maintains Overweight on Progyny, Raises Price Target to $35
Why Progyny (PGNY) Might be Well Poised for a Surge
What Makes Progyny (PGNY) a New Strong Buy Stock
Are You Looking for a Top Momentum Pick? Why Progyny (PGNY) is a Great Choice
Progyny (PGNY): Buy, Sell, or Hold Post Q1 Earnings?
Progyny Inc (NASDAQ:PGNY) Offers Affordable Growth With Strong Fundamentals
What Does the Sale of Progyny Shares by the CFO Mean for Investors?
Truist Securities Maintains Buy on Progyny, Raises Price Target to $33
What Progyny (PGNY)'s Governance Shift And $200 Million Buyback Mean For Shareholders
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.